share_log

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Apr 19 15:55
Summary by Moomoo AI
Jason N. Gorevic, a former officer and director of Teladoc Health, Inc., is set to sell 88,854 common shares of the company on April 19, 2024. The shares, which are expected to be sold for an aggregate market value of approximately $1,153,982.45, were acquired by Gorevic on April 18, 2024, as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a previous sale of 53,755 common shares by Gorevic in the past three months, which had gross proceeds of $780,286.09.
Jason N. Gorevic, a former officer and director of Teladoc Health, Inc., is set to sell 88,854 common shares of the company on April 19, 2024. The shares, which are expected to be sold for an aggregate market value of approximately $1,153,982.45, were acquired by Gorevic on April 18, 2024, as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a previous sale of 53,755 common shares by Gorevic in the past three months, which had gross proceeds of $780,286.09.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more